TG Therapeutics reported $594M in 2025 U.S. BRIUMVI sales, a 90% YoY increase, and guides for $825–$850M in 2026. Click here ...
Winchester Crown Court heard the group reached out to people smugglers in France who put adverts out on Snapchat 'fishing' ...
TG Therapeutics (NASDAQ:TGTX) executives highlighted rapid revenue growth for BRIUMVI in 2025, expanding adoption in ...
Luke Wachowiak sat at his dining room table on a recent Saturday afternoon, scrolling on his phone as a a nurse placed an IV in his arm.
Targeting pivotal top-line data for the subcutaneous BRIUMVI program in late 2025 or early 2026, which management believes ...
McKinney’s New Hub for Integrative Wellness McKinney, United States – February 26, 2026 / Oasis Medical Clinic & Spa / Oasis ...
Over the past year, RenovoRx has Tripled Commercially Active U.S. Cancer Centers and Centers Requesting Access to RenovoCath, its FDA-Cleared Device. Over 700 RenovoCath Procedure ...
Compounded NAD+ Telehealth Access, FDA Classification, Pharmacy Sourcing Standards, Prescription Requirements, and Consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results